Table 2 Patient recall of mpn diagnosis and classification
From: Patient perspectives of a diagnosis of myeloproliferative neoplasm in a case control study
| MPN subtypea | Patient reporting of MPN in the telephone questionnaire | Total | |||
|---|---|---|---|---|---|
| Did not report | Blood condition | Cancer | Other condition | ||
| PV | 5 (13.5 %) | 21 (56.8 %) | 6 (16.2 %) | 5 (13.5 %) | 37 |
| ET | 18 (32.7 %) | 16 (29.1 %) | 15 (27.3 %) | 6 (10.9 %) | 55 |
| PMF | 2 (14.3 %) | 5 (35.7 %) | 4 (28.6 %) | 3 (21.4 %) | 14 |
| Total | 25 (23.6 %) | 42 (39.6 %) | 25 (23.6 %) | 14 (13.2 %) | 106 |